Haining Lvsheng Medical Technology

Haining Lvsheng Medical Technology is a private China-based oncology company developing LS-HB, a small-molecule photosensitizer used in photodynamic therapy for cancer. Publicly visible pipeline data indicate the company has one disclosed clinical-stage program, LS-HB, which is being evaluated in a Phase 1 trial in patients with advanced malignant tumors, including obstructive esophageal cancer, non-small cell lung cancer with endobronchial obstruction, and head and neck cancer. The company appears to focus on tumor-directed photodynamic treatment rather than a broad multi-asset drug portfolio. Available sources suggest it was founded in 2011 in Zhejiang, China and remains active as a private company. Detailed corporate disclosures such as investors, website, and management team are limited in publicly accessible English-language sources.